This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her ...
Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the hospital ...
LOS ANGELES -- U.S. regulators issued new guidance this week shortening the time that people who received Moderna or Pfizer's COVID-19 vaccine have to wait for a booster, and it's different than the ...
The FDA approved clesrovimab (Enflonsia) to prevent lower respiratory tract disease from respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, drugmaker Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results